10 Pro-Life Companies to Invest In Now

3. Mirion Technologies, Inc. (NYSE:MIR)

Number of Hedge Funds: 43

Mirion Technologies, Inc. (NYSE:MIR) is a global leader in radiation detection, measurement, analysis, and monitoring solutions, serving diverse sectors such as nuclear energy, defense, medical, and scientific research. The company’s product portfolio includes dosimeters, contamination and clearance monitors, and radiation monitoring systems, all designed to ensure safety and operational efficiency in environments where ionizing radiation is present.

In Q4 2024, Mirion Technologies, Inc. (NYSE:MIR) reported record financial performance, with revenues increasing by 10.4% to $254.3 million compared to the same period in 2023. The company achieved a GAAP net income of $15.9 million, a significant turnaround from the $14.5 million net loss in the prior year’s quarter. Adjusted EBITDA also saw a 14.1% rise, reaching $69.6 million.

Mirion Technologies, Inc. (NYSE:MIR) has reaffirmed its guidance, anticipating total revenue growth between 4.0% and 6.0%, with organic revenue growth projected at 5.5% to 7.5%. The company also expects adjusted EBITDA to range from $215 million to $230 million and adjusted earnings per share between $0.45 and $0.50.

Analysts have taken note of Mirion’s strong performance and future potential. Analysts predict a price target of $20 from five ratings, all of which hold a Buy rating for the stock. Mirion Technologies, Inc. (NYSE:MIR) recently joined the Nuclear Energy Institute (NEI) and strengthened its partnership with the American Nuclear Society (ANS), which are two major nuclear industry organizations. However, insider selling has drawn attention, with Group President Loic Eloy selling $787K worth of shares at $17.89 each over the past year. Despite this, institutional investors hold 89.87% of shares, reflecting strong market confidence.